FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,121 | -100.0% | 309,359 | -0.6% | 0.02% | -57.4% |
| Q3 2022 | $6,977,000 | +45.4% | 311,331 | +60.8% | 0.05% | +54.3% |
| Q2 2022 | $4,798,000 | -31.5% | 193,637 | +7.2% | 0.04% | -14.6% |
| Q1 2022 | $7,003,000 | -32.9% | 180,620 | +4.0% | 0.04% | -24.1% |
| Q4 2021 | $10,434,000 | +24.0% | 173,704 | +22.4% | 0.05% | +17.4% |
| Q3 2021 | $8,413,000 | -31.7% | 141,951 | 0.0% | 0.05% | -39.5% |
| Q2 2021 | $12,320,000 | +561.3% | 141,951 | +528.1% | 0.08% | +533.3% |
| Q1 2021 | $1,863,000 | -9.3% | 22,600 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $2,055,000 | +576.0% | 22,600 | +197.4% | 0.01% | +600.0% |
| Q3 2020 | $304,000 | -62.9% | 7,600 | -68.2% | 0.00% | -71.4% |
| Q2 2020 | $820,000 | – | 23,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |